Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 9 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 307 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2017-10-06 | 2017-11-22 | 24666 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2019-10-18 | 2019-11-30 | 96823 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2020-05-22 | 2021-02-17 | 115612 |
| CLINDOXYL ADV GEL | 1% 3% | GEL | Resolved | 2023-08-03 | 2024-02-16 | 200926 |
| BREO ELLIPTA | 25MCG 100MCG | POWDER | Resolved | 2021-02-26 | 2021-03-05 | 134785 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2021-12-17 | 2022-01-05 | 151398 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2022-11-11 | 2022-12-01 | 174375 |
| BREO ELLIPTA | 100MCG 25MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178687 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-08 | 55706 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-08-31 | 2018-09-06 | 59702 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-10-05 | 2018-10-31 | 63383 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-22 | 75721 |
| BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-21 | 75724 |
| BEXSERO | 25MCG 50MCG 50MCG 50MCG | SUSPENSION | Resolved | 2024-01-12 | 2024-02-10 | 215839 |
| ANORO ELLIPTA | 25MCG 62.5MCG | POWDER | Resolved | 2019-01-23 | 2019-02-08 | 73358 |
| ANORO ELLIPTA | 25MCG 62.5MCG | POWDER | Resolved | 2020-04-03 | 2020-04-22 | 110852 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-02-19 | 2019-03-02 | 76337 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-12-18 | 2020-02-06 | 101563 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178691 |
| BREO ELLIPTA | 25MCG 200MCG | POWDER | Resolved | 2021-12-17 | 2022-01-05 | 151401 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| INFANRIX-IPV | 32UNIT 8UNIT 40UNIT 40UNIT 30UNIT 8MCG 25MCG 25MCG | SUSPENSION | Discontinued | 2021-10-28 | 2021-10-28 | 148433 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| HEPTOVIR | 5MG | SOLUTION | Discontinued | 2022-05-13 | 2022-07-22 | 160503 |
| HIBERIX | 10MCG | POWDER FOR SOLUTION | Discontinued | 2022-11-18 | 2023-03-29 | 175258 |
| TOCTINO | 10MG | CAPSULE | Discontinued | 2023-05-05 | 2023-07-01 | 191680 |
| TOCTINO | 30MG | CAPSULE | Discontinued | 2023-05-05 | 2023-07-01 | 191683 |
| STIEVA-A | 0.01% | CREAM | Discontinued | 2023-08-03 | 2024-03-20 | 200917 |
| STIEVA-A | 0.025% | CREAM | Discontinued | 2023-08-03 | 2023-11-29 | 200920 |
| STIEVA-A | 0.05% | CREAM | Discontinued | 2023-08-03 | 2023-11-10 | 200923 |
| NUCALA | 100MG | POWDER FOR SOLUTION | Discontinued | 2023-12-07 | 2023-12-07 | 212755 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| STIEPROX SHAMPOO | 1.5% | SHAMPOO | Discontinued | 2024-01-22 | 2024-01-23 | 216921 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| PAXIL TAB 10MG | 10MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224405 |
| PAXIL TAB 30MG | 30MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224430 |